Xeris Biopharma Inc. (XERS)
undefined
undefined%
At close: undefined

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -1.30 -0.48 -0.61 -0.43 -0.50 -0.85 -0.39 -0.71
PS Ratio 0.49 0.41 0.53 1.06 2.28 20.77 6.59 8.66
PB Ratio -11.93 1.00 1.28 0.55 1.36 0.68 -0.18 -0.29
P/FCF Ratio -1.64 -0.44 -0.56 -0.54 -0.57 -0.89 -0.40 -0.58
P/OCF Ratio -1.72 -0.44 -0.56 -0.55 -0.57 -0.91 -0.42 -0.58
OCF/S Ratio -0.07 -0.23 -0.23 -0.48 -1.00 -5.71 -3.96 -3.74
Debt / Equity Ratio -7.17 1.04 0.49 0.23 0.43 0.11 0.00 0.00
Quick Ratio 0.31 0.55 0.55 0.39 1.28 2.90 2.27 3.28
Current Ratio 0.41 0.63 0.63 0.45 1.35 2.90 2.27 3.28
Asset Turnover 0.51 0.32 0.32 0.16 0.13 0.02 0.03 0.03
Interest Coverage -0.41 -1.34 -1.34 -4.01 -1.96 -5.83 -3328.63 -1653.88
Return on Equity (ROE) 917.94% -209.49% -209.49% -128.87% -269.96% -79.68% 45.92% 41.36%
Return on Assets (ROA) -19.30%-27.48%-27.48%-40.32%-57.27%-50.05%-59.01%-39.39%
Return on Capital (ROIC) -19.35%-30.25%-30.25%-51.11%-63.80%-54.02%-66.34%-42.67%
Dividend Yield 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Gross Profit Margin 20.63% 19.87% 19.87% 18.29% 13.43% 24.57% 24.94% 24.81%
Net Profit Margin -9.50% -21.47% -21.47% -61.87% -113.05% -609.33% -426.64% -307.19%